Banerjee T, Pensi T, Banerjee D, Grover G
Department of Statistics, University of Delhi, Delhi, India.
Ann Trop Paediatr. 2010;30(1):27-37. doi: 10.1179/146532810X12637745451915.
In resource-limited countries, use of highly active antiretroviral therapy (HAART) in HIV-infected children is still poorly documented in terms of impact on survival, the immune system and growth. Since the availability of HAART, nutrition of HIV-infected children has been neglected.
To evaluate the effect of HAART on survival and immune response in HIV-infected children and to investigate the response to nutritional support.
In December, 2002 a cohort study was carried out on vertically HIV-1-infected children and was observed longitudinally for CD4(+) T-cell count, antiretroviral treatment and weight until 31 December 2007. Z-scores were calculated for CD4(+) T-cell count to account for age-related differences. Nutritional supplementation was given to all the HIV-infected children and resting energy expenditure (REE) was calculated. Mortality rates were also calculated for the perinatally infected children followed up at the HIV clinic.
A total of 180 children were assessed, 100 (56%) of whom were on HAART. Baseline body mass index was lower in the HAART group (p<0.05). Median duration of survival from date of diagnosis was 15.1 years. Those who received HAART survived significantly longer. The average annual mortality rate was 1.2% during 2005-2006. During HAART, a CD4 Z-score increase of 1 SD was associated with a 0.35 increase in body weight Z-score (p<0.001). The increase in daily energy intake owing to nutritional supplementation was associated with increase in weight Z-score in both the no-HAART and HAART group. REE was independently associated with weight change in the models which tested association of changes in CD4(+) T-cell Z-score and daily REE/kg body weight with changes in body weight Z-score in both the HAART and no-HAART group and then separately in the two groups (p<0.001).
Survival rates of children improved which correlated with an increase in CD4(+) T-cell count concurrent with the expanded use of HAART. HAART had a positive effect on growth in HIV-1-infected children. Nutrition supplementation improved the health of children in both the no-HAART and HAART groups.
在资源有限的国家,关于高效抗逆转录病毒疗法(HAART)对感染HIV儿童的生存、免疫系统及生长发育的影响,相关记录仍然很少。自HAART疗法问世以来,感染HIV儿童的营养状况一直被忽视。
评估HAART对感染HIV儿童生存及免疫反应的影响,并研究其对营养支持的反应。
2002年12月,对垂直感染HIV-1的儿童进行了一项队列研究,并对其CD4(+) T细胞计数、抗逆转录病毒治疗及体重进行纵向观察,直至2007年12月31日。计算CD4(+) T细胞计数的Z评分,以考虑年龄相关差异。对所有感染HIV的儿童给予营养补充,并计算静息能量消耗(REE)。还计算了在HIV诊所接受随访的围产期感染儿童的死亡率。
共评估了180名儿童,其中100名(56%)接受HAART治疗。HAART组的基线体重指数较低(p<0.05)。从诊断日期起的中位生存时间为15.1年。接受HAART治疗的儿童存活时间明显更长。2005 - 2006年期间的年均死亡率为1.2%。在HAART治疗期间,CD4 Z评分增加1个标准差与体重Z评分增加0.35相关(p<0.001)。在未接受HAART治疗组和HAART治疗组中,因营养补充导致的每日能量摄入增加均与体重Z评分增加相关。在测试HAART组和未接受HAART治疗组中CD4(+) T细胞Z评分变化及每日REE/千克体重变化与体重Z评分变化之间关联的模型中,以及随后在两组中分别进行分析时,REE与体重变化独立相关(p<0.001)。
随着HAART使用范围的扩大,儿童生存率提高,这与CD4(+) T细胞计数增加相关。HAART对感染HIV-1的儿童生长有积极影响。营养补充改善了未接受HAART治疗组和HAART治疗组儿童的健康状况。